Genetic aspects of alzheimer disease

Neurologist

Volumn 15, Issue 2, 2009, Pages 80-86

  Williamson, Jennifer ^a,b   Goldman, Jill ^a   Marder, Karen S ^a  

^a Columbia University ^*  (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

Author keywords

Alzheimer disease; Genetic counseling; Genetic testing; Genetics

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; PRESENILIN 1; PRESENILIN 2; SORTILIN;

ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN GENE; APOLIPOPROTEIN E GENE; GAB 2 GENE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC SUSCEPTIBILITY; HUMAN; ONSET AGE; PRESENILIN 1 GENE; PRESENILIN 2 GENE; PRIORITY JOURNAL; REVIEW; SORL 1 GENE;

ALZHEIMER DISEASE; ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS;

EID: 63449100233     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e318187e76b     Document Type: Review

References (43)

1. Association, A.s. Alzheimer's Disease Facts and Figures 2007. Available at: www.alz.org/national/documents/. Accessed 2007.
2. Tabaton M, Tamagno E. The molecular link between beta- and gamma- secretase activity on the amyloid beta precursor protein. Cell Mol Life Sci. 2007;64:2211-2218.
3. Sherrington R, Froelich S, Sorbi S, et al. Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum Mol Genet. 1996;5:985-988.
4. Tanzi RE, Vaula G, Romano DM, et al. Assessment of amyloid beta-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases. Am J Hum Genet. 1992;51:273-282.
5. Schellenberg GD, Bird TD, Wijsman EM, et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science. 1992;258: 668-671.
6. Van Broeckhoven C, Backhovens H, Crats M, et al. Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3. Nat Genet. 1992;2:335-339.
7. St George-Hyslop P, Haines J, Rogaev E, et al. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat Genet. 1992;2: 330-334.
8. Rogaev EI, Sherrington R, Rogaeva EA, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 1995;376:775-778.
9. Pericak-Vance MA, Bebout JL, Gaskell PC Jr, et al. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet. 1991;48:1034-1050.
10. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7:180-184.
11. Fairer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997;278:1349-1356.
12. Green RC, Cupples LA, Go R, et al. Risk of dementia among white and African American relatives of patients with Alzheimer disease. JAMA. 2002; 287:329-336.
13. Romas SN, Santana V, Williamson J, et al. Familial Alzheimer disease among Caribbean Hispanics: a reexamination of its association with APOE. Arch Neurol. 2002;59:87-91.
14. Bertram L, McQueen MB, Mullin K, et al. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet. 2007;39:17-23.
15. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273:1516-1517.
16. Gatz M, Fratiglioni L, Johansson B, et al. Complete ascertainment of dementia in the Swedish Twin Registry: the HARMONY study. Neurobiol Aging. 2005;26:439-447.
17. Gatz M, Reynolds CA, Fratiglioni L, et al. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry. 2006;63:168-174.
18. Li Y, Grape A, Rowland C, et al. DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. Hum Mol Genet. 2006; 15:2560-2568.
19. Bertram L, Tanzi RE. The genetic epidemiology of neurodegenerative disease. J Clin Invest. 2005;115:1449-1457.
20. Yamamoto M, Takahashi H, Nakamura T, et al. Developmental changes in distribution of death-associated protein kinase mRNAs. J Neurosci Res. 1999;58:674-683.
21. Mah AL, Perry G, Smith MA, et al. Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation. J Cell Biol. 2000;151:847-862.
22. Slifer MA, Martin ER, Haines JL, et al. The ubiquilin 1 gene and Alzheimer's disease. N Engl J Med. 2005;352:2752-2753; author reply 2752-2753.
23. Luchsinger JA, Tang MX, Shea S, et al. Hyperinsulinemia and risk of Alzheimer disease. Neurology. 2004;63:1187-1192.
24. Bertram L, Blacker D, Mullin K, et al. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science. 2000;290:2302-2303.
25. Vepsalainen S, Parkinson M, Helisalmi S, et al. Insulin-degrading enzyme is genetically associated with Alzheimer's disease in the Finnish population. J Med Genet. 2007;44:606-608.
26. Gunther C, von Hadeln K, Muller-Thomsen T, et al. Possible association of mitochondrial transcription factor A (TFAM) genotype with sporadic Alzheimer disease. Neurosci Lett. 2004;369:219-223.
27. Reiman EM, Webster JA, Myers AJ, et al. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron. 2007;54:713-720.
28. Rogaeva E, Meng Y, Lee JH, et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet. 2007; 39:168-177.
29. Li Y, Rowland C, Catanese J, et al. SORL1 variants and risk of late-onset Alzheimer's disease. Neurobiol Dis. 2008;29:293-296.
30. Meng Y, Lee JH, Cheng R, et al. Association between SORL1 and Alzheimer's disease in a genome-wide study. Neuroreport. 2007;18:1761-1764.
31. Webster JA, Myers AJ, Pearson JV, et al. Sorll as an Alzheimer's disease predisposition gene? Neurodegener Dis. 2008;5:60-64.
32. Mayeux R. Mapping the new frontier: complex genetic disorders. J Clin Invest. 2005;115:1404-1407.
33. Cupples LA, Farrer LA, Sadovnick AD, et al. Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study. Genet Med. 2004;6:192-196.
34. Williamson J, LaRusse S. Genetics and genetic counseling: recommendations for Alzheimer's disease, frontotemporal dementia, and Creutzfeldt-Jakob disease. Curr Neurol Neurosci Rep. 2004;4:351-357.
35. Athan ES, Williamson J, Ciappa A, et al. A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families. JAMA. 2001;286:2257-2263.
36. Campion D, Dumanchin C, Hannequin D, et al. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet. 1999;65:664-670.
37. Post SG, Whitehouse PJ, Binstock RH, et al. The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective. JAMA. 1997; 277:832-836.
38. Relkin NR, Kwon YJ, Tsai J, et al. The National Institute on Aging/ Alzheimer's Association recommendations on the application of apolipoprotein E genotyping to Alzheimer's disease. Ann N Y Acad Sci. 1996;802:149-176.
39. Mayeux R, Saunders AM, Shea S, et al. Utility of the apolipoprotein F. genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. N Engl J Med. 1998;338:506-511.
40. Tanzi RE. A genetic dichotomy model for the inheritance of Alzheimer's disease and common age-related disorders. J Clin Invest. 1999; 104:1175-1179.
41. Roberts JS, Cupples LA, Relkin NR, et al. Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study. J Geriatr Psvchiatrv Neurol. 2005;18:250-255.
42. Statement on use of apolipoprotein E testing for Alzheimer disease. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease. JAMA. 1995;274:1627-1629.
43. Guidelines for the molecular genetics predictive test in Huntington's disease. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea. Neurology. 1994;44:1533-1536.